세계의 항히스타민제 시장 : 약제 클래스별, 제형별, 적응증별, 투여 경로별, 유형별, 유통 채널별, 지역별
Global Antihistamine Drugs Market, By Drug Class, By Form, By Indication, By Route of Administration, By Type, By Distribution Channel, By Geography
상품코드
:
1699444
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 항히스타민제 시장은 2025년에는 1,017억 4,000만 달러로 추정되며, 2032년까지는 1,678억 달러에 달할 것으로 예측되며, 2025-2032년에 7.4%의 CAGR(연평균 성장률)로 성장할 것으로 예측됩니다.
| 리포트 범위 |
리포트 상세 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
1,017억 4,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : |
7.40% |
2032년 금액 예측 |
1,678억 달러 |
도표. 세계의 항히스타민제 시장 점유율(%), 지역별(2025년)
항히스타민제는 재채기, 가려움증, 콧물, 눈물 등의 알레르기 증상 치료에 사용되는 약물의 일종입니다. 항히스타민제는 알레르기 반응시 분비되는 체내 물질인 히스타민의 작용을 억제하여 효과를 발휘합니다. 항히스타민제는 크게 1세대 항히스타민제와 2세대 항히스타민제 두 가지로 나뉩니다. 항히스타민제는 약의 유형과 강도에 따라 일반의약품과 처방약으로 나뉩니다. 정제, 캡슐, 액상, 점비제, 점안제, 점안제 등 다양한 형태가 있습니다.
시장 역학:
항히스타민제 시장은 알레르기 유병률 증가, 신제품 출시, 혁신적인 제형 승인 등으로 인해 예측 기간 중 큰 성장을 보일 것으로 예상됩니다. 예를 들어 2021년 6월 미국 식품의약국(FDA)은 처방약에서 비처방약으로의 부분 전환으로 알려진 과정을 통해 비처방약용 비강용 항히스타민제를 승인했습니다. 미국 FDA는 아스테프로(아젤라스틴 염산염 비강 분무제, 0.15%)를 6세 이상의 성인과 어린이의 계절성 및 연중 알레르기성 비염(알레르기라고도 함)에 대해 승인했습니다.
본 조사의 주요 특징
- 세계의 항히스타민제(항히스타민제) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한 다양한 부문에 걸친 잠재적인 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략과 같은 다음 매개 변수를 기반으로 세계 항히스타민제 시장의 주요 기업을 프로파일링합니다.
- 본 조사의 대상이 되는 주요 기업에는 Bayer AG, Almirall, S.A., GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck &Co., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, Cipla 등이 포함됩니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 항히스타민제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 항히스타민제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
제3장 주요 인사이트
- 시장 역학
- 영향 분석
- PEST 분석
- Porter의 산업 분석
- 기술의 진보
- 합병, 인수, 협업 시나리오
- 최근 제품 승인
- 기업의 시장 점유율 분석
- 각 지역의 주요 기업의 특정
- 수출입 분석
- 규제 시나리오
- 가격 분석
- 제품 리콜
제4장 세계의 항히스타민제 시장, 약제 클래스별, 2020-2032년
- H-1 항히스타민제
- 제1세대
- 제2세대
- H-2 항히스타민제
제5장 세계의 항히스타민제 시장, 형태별, 2020-2032년
제6장 세계의 항히스타민제 시장, 적응증별, 2020-2032년
- 알레르기 질환
- 위장 장애
- 중추신경계 질환
- 피부 질환
- 기타
제7장 세계의 항히스타민제 시장, 투여 경로별, 2020-2032년
제8장 세계의 항히스타민제 시장, 유형별, 2020-2032년
제9장 세계의 항히스타민제 시장, 유통 채널별, 2020-2032년
제10장 세계의 항히스타민제 시장, 지역별, 2020-2032년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제11장 기업 개요 - 세계의 항히스타민제 시장
- GlaxoSmithKline
- 회사 개요
- 제품/서비스 포트폴리오
- 재무 실적
- 최근 동향/업데이트
- 전략 개요
- Bayer AG
- Almirall SA
- Johnson and Johnson
- Sanofi
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Merck &Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Viatris Inc.
- Arlak Biotech
- Aden Healthcare
- Sandoz Group AG
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories
- Cipla
제12장 참고 문헌과 조사 방법
KSA
영문 목차
Global Antihistamine Drugs Market is estimated to be valued at USD 101.74 Bn in 2025 and is expected to reach USD 167.80 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 101.74 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
7.40% |
2032 Value Projection: |
USD 167.80 Bn |
Figure. Global Antihistamine Drugs Market Share (%), By Region 2025
Antihistamine drugs are a class of medications that are used to treat symptoms of allergies, such as sneezing, itching, runny nose, and watery eyes. These drugs work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. There are two main types of antihistamines: First-generation antihistamines and second-generation antihistamine. Antihistamines are available over-the-counter and by prescription, depending on the specific medication and its strength. They come in various forms, including tablets, capsules, liquids, nasal sprays, and eye drops.
Market Dynamics:
The antihistamine drugs market is expected to witness significant growth over the forecast period owing to rise in the prevalence of allergies coupled, new product launches and approvals of innovative formulations. For instance, in June 2021, the U.S. Food and Drug Administration approved a nasal antihistamine for nonprescription use through a process known as a partial prescription to nonprescription switch. The U.S. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis (also known as allergies) in adults and children aged six and older.
Key Features of the Study:
- This report provides an in-depth analysis of the global antihistamine drugs market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global antihistamine drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Bayer AG, Almirall, S.A, GlaxoSmithKline, Johnson and Johnson, Sanofi, Pfizer Inc., Sun Pharmaceutical Industries Limited, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Viatris Inc., Arlak Biotech, Aden Healthcare, Sandoz Group AG, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories, and Cipla
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global antihistamine drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antihistamine drugs market
Detailed Segmentation:
- By Drug Class:
- H-1 Antihistamines
- First-generation
- Second-generation
- H-2 Antihistamines
- By Form:
- Liquid
- Tablets
- Capsules
- Gels
- Nasal Sprays
- Others
- By Indication:
- Allergic Disorders
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Dermatological Disorders
- Others
- By Route of Administration:
- By Type:
- By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Bayer AG
- Almirall S.A
- GlaxoSmithKline
- Johnson and Johnson
- Sanofi
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Viatris Inc.
- Arlak Biotech
- Aden Healthcare
- Sandoz Group AG
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories
- Cipla
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Form
- Market Snapshot, By Indication
- Market Snapshot, By Route of Administration
- Market Snapshot, By Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
- Market Opportunity Map
3. Key Insights
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancements
- Merger, Acquisition, and Collaboration Scenario
- Recent Product Approvals
- Company Market Share Analysis
- Identification of Key Players in Each Region
- Import-Export Analysis
- Regulatory Scenario
- Pricing Analysis
- Product Recalls
4. Global Antihistamine Drugs Market, By Drug Class, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- H-1 Antihistamines , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- First-generation, 2020 - 2032(US$ Billion)
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Second-generation, 2020 - 2032(US$ Billion)
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- H-2 Antihistamines , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
5. Global Antihistamine Drugs Market, By Form, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Liquid, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Tablets, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Capsules, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Gels, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Nasal Sprays, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Others , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
6. Global Antihistamine Drugs Market, By Indication, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Allergic Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Gastrointestinal Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Central Nervous System Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Dermatological Disorders, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Others , 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
7. Global Antihistamine Drugs Market, By Route of Administration, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Oral, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Parenteral, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Others, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
8. Global Antihistamine Drugs Market, By Type, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- OTC, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Prescription, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
9. Global Antihistamine Drugs Market, By Distribution Channel, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2021 - 2032
- Segment Trends
- Hospital Pharmacies, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Online Pharmacies, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
- Retail Pharmacies, 2020 - 2032(US$ Billion)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Billion)
10. Global Antihistamine Drugs Market, By Region, 2020 - 2032 (US$ Billion)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- China
- India
- Japan
- Australia
- South Korea
- Asean
- Rest Of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
- GCC
- Israel
- Rest Of The Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Form, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Indication, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
- South Africa
- North Africa
- Central Africa
11. Company Profiles - Global Antihistamine Drugs Market
- GlaxoSmithKline *
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
- Bayer AG
- Almirall S.A
- Johnson and Johnson
- Sanofi
- Pfizer Inc.
- Sun Pharmaceutical Industries Limited
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Abbott Laboratories
- Viatris Inc.
- Arlak Biotech
- Aden Healthcare
- Sandoz Group AG
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories
- Cipla
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
